Tolerance of Targeted Therapy Used in Metastatic Melanoma in Patients Aged Over 65 and 75-year-old
Clinical trial NCT03155217 · COMPLETED
Trial details
- NCT number
- NCT03155217
- Sponsor
- University Hospital, Montpellier
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2017-05-05
- Primary completion
- 2018-11-30
- Enrollment
- 358
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.